| Product Code: ETC6748822 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Nuclear Medicine Therapeutics Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Nuclear Medicine Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 China Nuclear Medicine Therapeutics Market - Industry Life Cycle |
3.4 China Nuclear Medicine Therapeutics Market - Porter's Five Forces |
3.5 China Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Nuclear Medicine Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 China Nuclear Medicine Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer and other chronic diseases in China leading to higher demand for nuclear medicine therapeutics |
4.2.2 Growing investments in healthcare infrastructure and technologies in China |
4.2.3 Favorable government initiatives and policies supporting the development and adoption of nuclear medicine therapeutics |
4.3 Market Restraints |
4.3.1 High cost associated with nuclear medicine therapeutics limiting accessibility for some patients |
4.3.2 Lack of skilled professionals and infrastructure for effective implementation of nuclear medicine therapeutics in China |
5 China Nuclear Medicine Therapeutics Market Trends |
6 China Nuclear Medicine Therapeutics Market, By Types |
6.1 China Nuclear Medicine Therapeutics Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Alpha Emitters, 2021- 2031F |
6.1.4 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Beta Emitters, 2021- 2031F |
6.1.5 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Brachy therapy, 2021- 2031F |
6.2 China Nuclear Medicine Therapeutics Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Oncology, 2021- 2031F |
6.2.3 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.2.4 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Thyroid, 2021- 2031F |
6.2.5 China Nuclear Medicine Therapeutics Market Revenues & Volume, By Other Applications, 2021- 2031F |
7 China Nuclear Medicine Therapeutics Market Import-Export Trade Statistics |
7.1 China Nuclear Medicine Therapeutics Market Export to Major Countries |
7.2 China Nuclear Medicine Therapeutics Market Imports from Major Countries |
8 China Nuclear Medicine Therapeutics Market Key Performance Indicators |
8.1 Number of new installations for nuclear medicine equipment in China |
8.2 Rate of adoption of nuclear medicine therapeutics in major hospitals and healthcare facilities |
8.3 Number of research and development collaborations between domestic and international companies in the nuclear medicine sector in China |
9 China Nuclear Medicine Therapeutics Market - Opportunity Assessment |
9.1 China Nuclear Medicine Therapeutics Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Nuclear Medicine Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 China Nuclear Medicine Therapeutics Market - Competitive Landscape |
10.1 China Nuclear Medicine Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 China Nuclear Medicine Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here